Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Finerenone, a novel nonsteroidal mineralocorticoid receptor antagonist, works by blocking the mineralocorticoid receptor. This action leads to a reduction in fibrosis and inflammation, which are commonly observed in many patients suffering from heart failure (4).
In the context of Finerenon & Heart Failure / Congestive heart failure (CHF), there is now an FDA approval for finerenone in certain forms of Heart Failure / Congestive heart failure (CHF), but with specific ejection‑fraction criteria (1, 2, 3, 4)
T…